NEUROPRO TECHNOLOGIES INC has a total of 19 patent applications. It decreased the IP activity by 100.0%. Its first patent ever was published in 2002. It filed its patents most often in WIPO (World Intellectual Property Organization), Australia and United States. Its main competitors in its focus markets medical technology, pharmaceuticals and biotechnology are MERCK BIOMATERIAL FRANCE, ADLER ORTHO S P A and IMPACT.
# | Country | Total Patents | |
---|---|---|---|
#1 | WIPO (World Intellectual Property Organization) | 6 | |
#2 | Australia | 5 | |
#3 | United States | 4 | |
#4 | China | 1 | |
#5 | India | 1 | |
#6 | Republic of Korea | 1 | |
#7 | Philippines | 1 |
# | Industry | |
---|---|---|
#1 | Medical technology | |
#2 | Pharmaceuticals | |
#3 | Biotechnology |
# | Technology | |
---|---|---|
#1 | Implantable devices | |
#2 | Diagnosis and surgery | |
#3 | Medical preparations | |
#4 | Object sterilising | |
#5 | Therapeutic chemical compounds | |
#6 | Peptides |
# | Name | Total Patents |
---|---|---|
#1 | Remington Benjamin J | 17 |
#2 | Mcluen Gary R | 12 |
#3 | Baker Daniel R | 12 |
#4 | Logan Joseph N | 11 |
#5 | Stalcup Gregory C | 9 |
#6 | Bearss David J | 7 |
#7 | Shahi Kavian | 7 |
#8 | Gerbec Daniel E | 1 |
Publication | Filing date | Title |
---|---|---|
US2004002168A1 | Apparatus and methods for detecting cerebrospinal fluid | |
US7041309B2 | Spinal fusion using an HMG-CoA reductase inhibitor |